The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
The Effects of Amiodarone on the Thyroid*
Abstract
Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes in thyroid function tests (typically an increase in serum T(4) and rT(3), and a decrease in serum T(3), concentrations), mainly related to the inhibition of 5'-deiodinase activity, resulting in a decrease in the generation of T(3) from T(4) and a decrease in the clearance of rT(3). In 14-18% of amiodarone-treated patients, there is overt thyroid dysfunction, either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). Both AIT and AIH may develop either in apparently normal thyroid glands or in glands with preexisting, clinically silent abnormalities. Preexisting Hashimoto's thyroiditis is a definite risk factor for the occurrence of AIH. The pathogenesis of iodine-induced AIH is related to a failure to escape from the acute Wolff-Chaikoff effect due to defects in thyroid hormonogenesis, and, in patients with positive thyroid autoantibody tests, to concomitant Hashimoto's thyroiditis. AIT is primarily related to excess iodine-induced thyroid hormone synthesis in an abnormal thyroid gland (type I AIT) or to amiodarone-related destructive thyroiditis (type II AIT), but mixed forms frequently exist. Treatment of AIH consists of L-T(4) replacement while continuing amiodarone therapy; alternatively, if feasible, amiodarone can be discontinued, especially in the absence of thyroid abnormalities, and the natural course toward euthyroidism can be accelerated by a short course of potassium perchlorate treatment. In type I AIT the main medical treatment consists of the simultaneous administration of thionamides and potassium perchlorate, while in type II AIT, glucocorticoids are the most useful therapeutic option. Mixed forms are best treated with a combination of thionamides, potassium perchlorate, and glucocorticoids. Radioiodine therapy is usually not feasible due to the low thyroidal radioiodine uptake, while thyroidectomy can be performed in cases resistant to medical therapy, with a slightly increased surgical risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
Kudenchuk, P. J., Cobb, L. A., Copass, M. K., Cummins, R. O., Doherty, A. M., Fahrenbruch, C. E., Hallstrom, A. P., Murray, W. A., Olsufka, M., & Walsh, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411203 · Cited by 809
Perchlorate and the Thyroid Gland
Wolff, J. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01350-4 · Cited by 588
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud, E. G., Strickberger, S. A., Man, K. C., Goyal, R., Deeb, G. M., Bolling, S. F., Pagani, F. D., Bitar, C., Meissner, M. D., & Morady, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372501 · Cited by 529
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-28 · Cited by 370
Self-citationPhosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis
Tarui, S., Giichi, O., Ikura, Y., Tanaka, T., Suda, M., & Nishikawa, M. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90156-7 · Cited by 369
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
Ceremuzynski, L., Kleczar, E., Krzeminska-Pakula, M., Kuch, J., Nartowicz, E., Smielak-Korombel, J., Dyduszynski, A., Maciejewicz, J., Zaleska, T., Lazarczyk-Kedzia, E., et al. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90357-s · Cited by 298
WOLFF, J., CHAIKOFF, I. L., GOLDBERG, R. C., & MEIER, J. R. (1949) · Endocrinology · doi:10.1210/endo-45-5-504 · Cited by 292
Effects of Amiodarone on Thyroid Function
Harjai, K. J., & Licata, A. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00009 · Cited by 273
Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism
Trip, M. D., Wiersinga, W., & Plomp, T. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90187-3 · Cited by 267
Bartalena, L. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2930 · Cited by 238
Self-citation[Effects of amiodarone on thyroid function].
Caron, P. J. (1995) · PubMed · Cited by 234
ALLEN, E. M., APPEL, M. C., & BRAVERMAN, L. E. (1986) · Endocrinology · doi:10.1210/endo-118-5-1977 · Cited by 209
Self-citationBartalena, L., Bogazzi, F., Braverman, L. E., & Martino, E. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343825 · Cited by 199
Self-citationBOGAZZI, F., BARTALENA, L., BROGIONI, S., MAZZEO, S., VITTI, P., BURELLI, A., BARTOLOZZI, C., & MARTINO, E. (1997) · Thyroid · doi:10.1089/thy.1997.7.541 · Cited by 193
Self-citationEnhanced Susceptibility to Iodide Myxedema in Patients with Hashimoto's Disease
BRAVERMAN, L. E., INGBAR, S. H., VAGENAKIS, A. G., ADAMS, L., & MALOOF, F. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-32-4-515 · Cited by 184
Self-citationInduction of Autoimmune Thyroiditis in Chickens by Dietary Iodine
Bagchi, N., Brown, T. R., Urdanivia, E., & Sundick, R. S. (1985) · Science · doi:10.1126/science.4048936 · Cited by 178
Serum interleukin-6 in amiodarone-induced thyrotoxicosis
Bartalena, L. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.2.423 · Cited by 174
Self-citationVitale, M., Di Matola, T., D’Ascoli, F., Salzano, S., Bogazzi, F., Fenzi, G., Martino, E., & Rossi, G. (2000) · Endocrinology · doi:10.1210/endo.141.2.7291 · Cited by 173
Self-citationMELMED, S., NADEMANEE, K., REED, A. W., HENDRICKSON, J. A., SINGH, B. N., & HERSHMAN, J. M. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-5-997 · Cited by 158
ENZYMATIC OR PHARMACOLOGICAL FIBRINOLYSIS?
Marshall, M. (1964) · PubMed · Cited by 154
Newman, C. M. H., Price, A., Davies, D., Gray, T. A., & Weetman, A. P. (1998) · Heart · doi:10.1136/hrt.79.2.121 · Cited by 150
Amiodarone-Associated Thyroid Dysfunction
Thorne, S., Barnes, I. M., Cullinan, P., & Somerville, J. (1999) · Circulation · doi:10.1161/01.cir.100.2.149 · Cited by 149
Martino, E., Aghini-Lombardi, F., Mariotti, S., Lenziardi, M., Baschieri, L., Braverman, L. E., & Pinchera, A. (1986) · Journal of Endocrinological Investigation · doi:10.1007/bf03348098 · Cited by 149
Self-citationPregnancy outcome after gestational exposure to amiodarone in Canada
Magee, L. A., Downar, E., Sermer, M., Boulton, B. C., Allen, L. C., & Koren, G. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91498-6 · Cited by 142
Pathology of the Thyroid in Amiodarone-Associated Thyrotoxicosis
Smyrk, T. C., Goellner, J. R., BRENNAN, M. D., & Carney, J. A. (1987) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198703000-00004 · Cited by 127
Wenzel, K. W., & LENTE, J. R. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-1-62 · Cited by 119
AMIODARONE IODINE‐INDUCED HYPOTHYROIDISM: RISK FACTORS AND FOLLOW‐UP IN 28 CASES
Martino, E., Aghini-Lombardi, F., Mariotti, S., Bartalena, L., Lenziardi, M., Ceccarelli, C., Bambini, G., Safran, M., Braverman, L. E., & Pinchera, A. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00781.x · Cited by 119
Self-citationIodine Kinetic Studies during Amiodarone Treatment*
Rao, R. H., McCready, V. R., & Spathis, G. S. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-3-563 · Cited by 116
Effects of Triiodothyronine and Amiodarone on the Promoter of the Human LDL Receptor Gene
Bakker, O., Hudig, F., Meijssen, S., & Wiersinga, W. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9174 · Cited by 114
Sogol, P. B., Hershman, J. M., REED, A. W., & DILLMANN, W. H. (1983) · Endocrinology · doi:10.1210/endo-113-4-1464 · Cited by 108
Amiodarone: A Common Source of Iodine-Induced Thyrotoxicosis
Martino, E., Aghini-Lombardi, F., Mariotti, S., Bartalena, L., Braverman, L. E., & Pinchera, A. (2008) · Hormone Research · doi:10.1159/000180696 · Cited by 108
Self-citationIodine‐induced thyrotoxicosis: analysis of eighty‐five consecutive cases
Léger, A., MASSIN, J. P., Laurent, M. F., Vincens, M., Auriol, M., Helal, O. B., Chomette, G., & Savoie, J. C. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb01212.x · Cited by 108
Studies on the in vitro cytotoxic effect of amiodarone.
Chiovato, L., Martino, E., Tonacchera, M., Santini, F., Lapi, P., Mammoli, C., Braverman, L. E., & Pinchera, A. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156930 · Cited by 107
Self-citationAmiodarone therapy and autoimmune thyroid disease
Rabinowe, S. L., Larsen, P. R., Antman, E. M., George, K. L., Friedman, P. L., Jackson, R. A., & Eisenbarth, G. S. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90181-6 · Cited by 105
VIRAL DIAGNOSIS BY IMMUNOFLUORESCENCE
Gardner, P. S., McQuillin, J., Gray, K., Macfarlane, D. E., & Sommerville, R. G. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92876-6 · Cited by 103
Thyroidectomy for Amiodarone-Induced Thyrotoxicosis
Farwell, A. P. (1990) · JAMA · doi:10.1001/jama.1990.03440110092034 · Cited by 103
Clinical and Chemical Assessment of Thyroid Function During Therapy With Amiodarone
Amico, J. A., Richardson, V., Alpert, B., & Klein, I. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150071023 · Cited by 103
Amiodarone therapy during pregnancy
McKenna, W. J., Harris, L., Rowland, E., Storey, G., & Holt, D. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90377-6 · Cited by 96
Krenning, E. P., Docter, R., Bernard, B. F., Visser, T. J., & HENNEMANN, G. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80900-9 · Cited by 96
Thyroid dysfunction during chronic amiodarone therapy
Albert, S. G., Alves, L. E., & Rose, E. P. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80098-0 · Cited by 92
Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.
Monteiro, E., Galvão-Teles, A., Santos, M. L., Mourão, L., Correia, M. J., Jl, T., & Ribeiro, C. (1986) · BMJ · doi:10.1136/bmj.292.6515.227 · Cited by 91
Lithium treatment in amiodarone-induced thyrotoxicosis
Dickstein, G., Shechner, C., Adawi, F., Kaplan, J., Baron, E., & Ish-Shalom, S. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00047-8 · Cited by 87
Roti, E., Minelli, R., Gardini, E., Bianconi, L., & Braverman, L. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.7.886 · Cited by 86
Self-citationInterleukin-6: a marker of thyroid-destructive processes?
Bartalena, L., Brogioni, S., Grasso, L., Rago, T., Vitti, P., Pinchera, A., & Martino, E. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962338 · Cited by 82
Self-citationAMIODARONE AND THYROID HORMONE ACTION JAYNE A.
Franklyn, J. A., Davis, J. R., GAMMAGE, M. D., Littler, W. A., Ramsden, D. B., & Sheppard, M. C. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb03238.x · Cited by 80
Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function
Borowski, G. D., GAROFANO, C. D., Rose, L. I., Spielman, S. R., Rotmensch, H. R., Greenspan, A. M., & Horowitz, L. N. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90336-5 · Cited by 80
Kennedy, R. L., Griffiths, H., & Gray, T. A. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.9.1882 · Cited by 79
Martino, E. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230115013 · Cited by 76
Self-citationAntagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.
Norman, M. F., & Lavin, T. N. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113874 · Cited by 73
Bakker, O., van Beeren, H. C., & Wiersinga, W. M. (1994) · Endocrinology · doi:10.1210/endo.134.4.8137729 · Cited by 73
Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy
Widerhorn, J., Bhandari, A. K., Bughi, S., Rahimtoola, S. H., & Elkayam, U. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90489-5 · Cited by 71
Use of amiodarone during pregnancy
Plomp, T. A., Vulsma, T., & de Vijlder, J. J. M. (1992) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(92)90174-w · Cited by 70
Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction
Martino, E., Bartalena, L., Mariotti, S., Aghini-Lombardi, F., Ceccarelli, C., Lippi, F., Piga, M., Loviselli, A., Braverman, L. E., Safran, M., et al. (1988) · European Journal of Endocrinology · doi:10.1530/acta.0.1190167 · Cited by 69
Self-citationPitsiavas, V., Smerdely, P., Li, M., & Boyages, S. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370089 · Cited by 68
Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management.
Brennan, van Heerden, J. A., & Carney, J. A. (1987) · PubMed · Cited by 68
Reichert, L. J. M., & de Rooy, H. A. (1989) · BMJ · doi:10.1136/bmj.298.6687.1547 · Cited by 65
Pharmacokinetics and body distribution of amiodarone in man.
Plomp, T. A., van Rossum, J. M., de Medina, E. O. R., Lier, T. V., & Maes, R. A. A. (1984) · PubMed · Cited by 65
van Beeren, H. C., Bakker, O., & Wiersinga, W. M. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03578-u · Cited by 64
Gembruch, U., MANZ, M., Bald, R., Ruddel, H., Redel, D. A., Schlebusch, H., NITSCH, J., & Hansmann, M. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90028-8 · Cited by 63
Nademanee, K., Singh, B. N., Callahan, B. L., Hendrickson, J. A., & Hershman, J. M. (1986) · The American Journal of Cardiology · doi:10.1016/s0002-9149(86)80023-6 · Cited by 62
Wiersinga, W. M. (1997) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60709-7_10 · Cited by 62
BRENNAN, M. D., ERICKSON, D. Z., CARNEY, J. A., & BAHN, R. S. (1995) · Thyroid · doi:10.1089/thy.1995.5.177 · Cited by 61
Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes
Beddows, S. A., Page, S. R., Taylor, A. H., McNerney, R., Whitley, G. S. J., Johnstone, A. P., & Nussey, S. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90648-5 · Cited by 61
IS HUMORAL THYROID AUTOIMMUNITY RELEVANT IN AMIODARONE IODINE‐INDUCED THYROTOXICOSTS (AIIT)?
Martino, E., Macchia, E., Aghini-Lombardi, F., ANTONELLI, A., Lenziardi, M., Concetti, R., Fenzi, G. F., Baschieri, L., & Pinchera, A. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01658.x · Cited by 61
Self-citationCongenital Hypothyroid Goiter and Amiodarone
Wolf, D. D., Schepper, J. D., Verhaaren, H. A., Deneyer, M., Smitz, J. E. J., & Sacré‐Smits, L. (1988) · Acta Paediatrica · doi:10.1111/j.1651-2227.1988.tb10717.x · Cited by 61
Amiodarone and digoxin for refractory fetal tachycardia
Arnoux, P., Seyral, P., Llurens, M., DJIANE, P., Potier, A., Unal, D., Cano, J. P., Serradimigni, A., & Rouault, F. (1987) · The American Journal of Cardiology · doi:10.1016/s0002-9149(87)80095-4 · Cited by 60
The Relative Toxicity of Antithyroid Drugs
Trotter, W. (1962) · The Journal of New Drugs · doi:10.1177/009127006200200603 · Cited by 59
Bartalena, L., Brogioni, S., Grasso, L., & Martino, E. (1993) · Journal of Endocrinological Investigation · doi:10.1007/bf03344951 · Cited by 57
Self-citationPrednisone in amiodarone-induced thyrotoxicosis.
Wimpfheimer, C., Stäubli, M., Schädelin, J., & Studer, H. (1982) · BMJ · doi:10.1136/bmj.284.6332.1835-a · Cited by 54
Amiodarone Inhibits the Conversion of Thyroxine to Triiodothyronine in Isolated Rat Hepatocytes
Aanderud, S., Sundsfjord, J., & Aarbakke, J. (1984) · Endocrinology · doi:10.1210/endo-115-4-1605 · Cited by 54
Broussolle, C., Ducottet, X., Martin, C., Barbier, Y., Bornet, H., Noel, G., & Orgiazzi, J. (1989) · Journal of Endocrinological Investigation · doi:10.1007/bf03349916 · Cited by 53
Newnham, H. H., Topliss, D. J., GRAND, B. A. L., Chosich, N., Harper, R. W., & Stockigt, J. R. (1988) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1988.tb02237.x · Cited by 52
Acute Effects of Amiodarone Administration on Thyroid Function in Patients with Cardiac Arrhythmia
Iervasi, G., Clerico, A., Bonini, R., Manfredi, C., Berti, S. L., Ravani, M., Palmieri, C., Carpi, A., Biagini, A., & CHOPRA, I. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3675 · Cited by 52
Myxedema coma during long-term amiodarone therapy
Mazonson, P. D., Williams, M. L., Cantley, L. K., Dalldorf, F. G., Utiger, R. D., & Foster, J. R. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90379-6 · Cited by 52
Roti, E., Minelli, R., Gardini, E., Bianconi, L., Gavaruzzi, G., Ugolotti, G., Neri, T. M., & Braverman, L. E. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.5.1331165 · Cited by 51
Self-citationTwenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis.
Martino, E., Aghini-Lombardi, F., Lippi, F., Baschieri, L., Safran, M., Braverman, L. E., & Pinchera, A. (1985) · PubMed · Cited by 50
Self-citationChronic administration of amiodarone and thyroid function: A follow-up study
Sanmartí, A., Permanyer‐Miralda, G., Castellanos, J. M., Foz, M., Galard, R., & Soler‐Soler, J. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90751-8 · Cited by 47
Trip, M. D., Düren, D. R., & Wiersinga, W. M. (1994) · Heart · doi:10.1136/hrt.72.3.266 · Cited by 46
Martino, E., Mariotti, S., Aghini-Lombardi, F., Lenziardi, M., MORABITO, S., Baschieri, L., Pinchera, A., Braverman, L. E., & Safran, M. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-5-1233 · Cited by 46
Self-citationTreatment of fetal cardiac arrhythmias.
Wladimiroff, J. W., & Pa, S. (1985) · PubMed · Cited by 46
Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.
Mulligan, D. C., McHenry, C. R., Kinney, W., & Esselstyn, C. B. (1993) · PubMed · Cited by 45
Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone
Hershman, J. M., Nademanee, K., Sugawara, M., Pekary, A. E., Ross, R., Singh, B. N., & DiStefano, J. J. (1986) · European Journal of Endocrinology · doi:10.1530/acta.0.1110193 · Cited by 45
Amiodarone‐induced thyrotoxicosis: Is there a place for surgery?
Meurisse, M., Hamoir, E., D'Silva, M., Joris, J., & Hennen, G. (1993) · World Journal of Surgery · doi:10.1007/bf01659125 · Cited by 43
Mariotti, S., Loviselli, A., Murenu, S., Sau, F., Valentino, L., Mandas, A., Vacquer, S., Martino, E., Balestrieri, A., & Lai, M. (1999) · Journal of Endocrinological Investigation · doi:10.1007/bf03345479 · Cited by 43
Self-citationAmiodarone in pregnancy. Case report and review of the literature
Foster, C. J., & Love, H. G. (1988) · International Journal of Cardiology · doi:10.1016/0167-5273(88)90285-9 · Cited by 42
A consensus report on antiarrhythmic drug use
Reiffel, J. A., Estes, N. A. M., Waldo, A. L., Prystowsky, E. N., & DiBianco, R. (1994) · Clinical Cardiology · doi:10.1002/clc.4960170303 · Cited by 42
Amiodarone and the thyroid gland. A review.
Mh, J. (1981) · PubMed · Cited by 40
Pitcher, D., Leather, H. M., Storey, G., & Holt, D. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92853-2 · Cited by 39
Amiodarone Induced Hyperthyroidism: A Case Series and Brief Review of Literature
Harjai, K. J., & Licata, A. A. (1996) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1996.tb03179.x · Cited by 38
Clinical Characteristics of Amiodarone-Induced Thyrotoxicosis and Hypothyroidism in Japan.
Sato, K., Miyakawa, M., Eto, M., Inaba, T., Matsuda, N., Shiga, T., Ohnishi, S., & Kasanuki, H. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.443 · Cited by 37
Amiodarone-Induced Thyroid Dysfunction
Iudica-Souza, C., & Burch, H. B. (1999) · The Endocrinologist · doi:10.1097/00019616-199905000-00008 · Cited by 36
Uzzan, B., Pussard, E., Leon, A., Bekhechi, D., Krivitzky, A., Modigliani, E., Perret, G. Y., Vassy, R., Berdeaux, A., & Giudicelli, J. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05548.x · Cited by 36
STRUNGE, P., FRANDSEN, J., & ANDREASEN, P. (1988) · European Heart Journal · doi:10.1093/ehj/9.1.106 · Cited by 35
Wiersinga, W. M., TOUBER, J. L., Trip, M. D., & van Royen, E. A. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-485 · Cited by 35
Catte, L. D., Wolf, D. D., Smitz, J. E. J., Bougatef, A., Schepper, J. D., & Foulon, W. (1994) · Prenatal Diagnosis · doi:10.1002/pd.1970140819 · Cited by 35
Neurodevelopment After In Utero Amiodarone Exposure
Magee, L. A., Nulman, I., ROVET, J. F., & Koren, G. (1999) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(98)00052-x · Cited by 34
Amiodarone-induced hyperthyroidism: Thyroidectomy under local anesthesia
Mehra, A., Widerhorn, J., LoPresti, J. S., et al. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90488-4 · Cited by 33
Safran, M., Fang, S.-L., Bambini, G., Pinchera, A., Martino, E., & Braverman, L. E. (1986) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198609000-00003 · Cited by 33
Self-citationNeonatal hypothyroidism after treatment by amiodarone during pregnancy
Laurent, M., Bétrémieux, P., Biron, Y., & Lebelloco, A. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91070-8 · Cited by 32
Transient neonatal hypothyroidism after gestational exposure to amiodarone: A follow-up of two cases
Grosso, S., Berardi, R., Cioni, M., & Morgese, G. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350801 · Cited by 31
Use of amiodarone during pregnancy
Robson, D. J., Raj, M., Storey, G., & Holt, D. W. (1985) · Postgraduate Medical Journal · doi:10.1136/pgmj.61.711.75 · Cited by 31
Amiodarone and thyroid autoimmunity in the United Kingdom.
Weetman, A. P., Bhandal, S., Burrin, J. M., Robinson, K. A., & McKenna, W. J. (1988) · BMJ · doi:10.1136/bmj.297.6640.33 · Cited by 31
Figge, J., & Dluhy, R. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-7-553 · Cited by 30
Rey, É., Duperron, L., Gauthier, R., Lemay, M., Grignon, A., & LeLorier, J. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(85)80120-4 · Cited by 29
Amiodarone‐induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA
Hudig, F., Bakker, O., & Wiersinga, W. M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80245-9 · Cited by 28
Davies, P. H. O., Franklyn, J. A., & Sheppard, M. C. (1992) · BMJ · doi:10.1136/bmj.305.6847.224 · Cited by 26
Outcome of Thyroid Function in Newborns from Mothers Treated with Amiodarone
Matsumura, L. K., BORN, D., Kunii, I. S., FRANCO, D. B., & Maciel, R. M. B. (1992) · Thyroid · doi:10.1089/thy.1992.2.279 · Cited by 26
Pitsiavas, V., Smerdely, P., & Boyages, S. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400241 · Cited by 23
Penn, I. M., Barrett, P. A., Pannikote, V., Barnaby, P. F., Campbell, J. B., & Lyons, N. R. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90596-x · Cited by 22
Amiodarone-Induced Thyrotoxicosis Associated with Thyrotropin Receptor Antibody
Sato, K., Yamazaki, K., KANAJI, Y., Ohnishi, S., Kasanuki, H., & Demura, H. (1998) · Thyroid · doi:10.1089/thy.1998.8.1123 · Cited by 21
Effects of amiodarone during pregnancy.
Rey, É., Bachrach, L. K., & Burrow, G. N. (1987) · PubMed · Cited by 19
Thyroid Hormone α1 and β1 Receptor mRNA are Downregulated by Amiodarone in Mouse Myocardium
Shahrara, S., & Drvota, V. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199908000-00012 · Cited by 19
Hudig, F., Bakker, O., & Wiersinga, W. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90277-3 · Cited by 19
Bonnyns, M., Sterling, I., Renard, M., Bernard, R., Demaret, B., & Bourdoux, P. (1989) · PubMed · Cited by 17
Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis
Stäubli, M., & Studer, H. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01732171 · Cited by 17
Towards an animal model of amiodarone-induced thyroid dysfunction
Wiersinga, W. M. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370015 · Cited by 17
Amiodarone-induced thyrotoxicosis: four cases and a review of the literature
Keidar, S., Grenadier, E., & Palant, A. (1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.655.356 · Cited by 17
Amiodarone-induced thyroiditis
Leung, W., Pun, K.-K., Lau, C., Wong, C., & Wang, C. E. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90602-9 · Cited by 16
Balzano, S., Sau, F., Bartalena, L., Ruscazio, M., Balestrieri, A., Cherchi, A., & Martino, E. (1987) · Journal of Endocrinological Investigation · doi:10.1007/bf03347002 · Cited by 16
Self-citationRani, C. S. S. (1990) · Endocrinology · doi:10.1210/endo-127-6-2930 · Cited by 15
Adli, H., Bazin, R., & Perret, G. Y. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702456 · Cited by 13
Valensise, H. C. C., Civitella, C., Garzetti, G. G., & Romaninï, C. (1992) · Prenatal Diagnosis · doi:10.1002/pd.1970120903 · Cited by 12
van Beeren, H. C., Bakker, O., Chatterjee, K., & Wiersinga, W. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00453-6 · Cited by 12
Amiodarone: The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis
Donaghue, K. C., Clarke, P., & Hooper, M. J. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb113526.x · Cited by 12
Weweire, A. D., Unger, P., Delwiche, F., Unger, J., Martino, E., Mariotti, S., Aghini-Lombardi, F., Pinchera, A., Baschieri, L., & Braverman, L. E. (1987) · Journal of Endocrinological Investigation · doi:10.1007/bf03348187 · Cited by 10
Self-citationSuppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis
WEISSEL, M. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350098 · Cited by 8
[Amiodarone and thyroid function].
Jonckheer, M. H., Broeckaert, I., Blockx, P. P., et al. (1976) · PubMed · Cited by 6
Blossey, H. C., & Peitsch, W. (1988) · PubMed · Cited by 5
Cited by
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Metadata
- Authors
- Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 240-254
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2117317136
- Cited by
- 551
- References
- 133
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.